Want to join the conversation?
$ANTM posted lower earnings in 2Q16, hurt by higher expenses compared to 2Q15. Net income was $780.6MM or $2.91 per diluted share compared to $859.1MM or $3.13 per diluted share last year. Operating revenue was nearly $21.3Bil in 2Q16, an increase of approx. $1.5Bil or 7.7% versus the nearly $19.8Bil in 2Q15. Adjusted EPS was $3.33 in the quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?